Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
65.98 EUR | +0.76% | +1.38% | -20.72% |
May. 31 | BRENNTAG : UBS remains its Buy rating | ZD |
May. 31 | BRENNTAG : Jefferies remains Neutral | ZD |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Diversified Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-20.72% | 10.33B | B | ||
-1.05% | 74.34B | B | ||
-0.76% | 46.86B | A- | ||
+6.80% | 34.35B | C | ||
+9.37% | 18.1B | B | ||
+12.81% | 11.92B | A- | ||
-3.01% | 10.43B | - | ||
-1.35% | 9.04B | A- | ||
-11.01% | 7.84B | C- | ||
-3.85% | 7.52B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- BNR Stock
- Ratings Brenntag SE